Introduction
Motility of ejaculated spermatozoa is an important parameter of sperm function, which has been recognized as an integral part of a semen analysis. Poor motility of sperm results in infertility.
Immotile and slow moving sperm are unable to penetrate the cervical mucous and fertilize the ovum. Therefore, sperm motility plays a vital role in fertility [1, 2] . Human sperm motility is affected Objective: To test the effect of voltage-gated sodium channels (VGSCs) blockers on the motility and viability of human sperm in-vitro and to evaluate the tested compounds as potential contact spermicidal. Methods: Sperm samples were obtained from healthy nonsmoking volunteers of age 25-30 years who had not taken any drug 3 months before and during the course of the study. The effect of VGSCs blockers evaluated from two pharmacological classes including antiarrhythmic (amiodarone, procainamide and disopyramide) and antiepileptic (carbamazepine, oxcarbazepine, phenytoin, and lamotrigine) drugs. They were tested on the in-vitro motility and viability of human sperm using Computer Assisted Semen Analyzer. Results: All tested drugs except oxcarbazepine showed dose dependent inhibition of total motility with significant reduction (P<0.05) at the maximum concentration of 200 µM when compared with the control. The concentrations of drugs that reduced total sperm motility to 50% of control (half maximal inhibitory concentration) were 2.76, 14.16 and 20.29 µM for phenytoin, lamotrigine and carbamazepine, respectively; and 2.53, 5.32 and 0.37 µM for amiodarone, procainamide and disopyramide, respectively. The anti-motility effects were reversible to various degrees. There was statistically insignificant difference in the inhibition of sperm viability among amiodarone, procainamide and disopyramide. Phenytoin demonstrated the most potent spermicidal action. Conclusions: VGSCs blockers have significant adverse effects on in-vitro motility of human spermatozoa. So in-vivo studies are required to determine their potential toxicological effects on human semen quality, which is an important factor regarding fertility. Moreover, these drugs have the potential to be developed into contact spermicidal.
by a variety of drugs from different pharmacological classes [3] , which exert their impacts via a number of mechanisms including regulation of calcium signaling [4] and action on various receptors like histamine [5] , cannabinoid [6] , dopamine and neurotransmitter gammaaminobutyric acid receptors [7] . These interactions of drugs with human sperm suggest that many of the commonly prescribed drugs may have the potential to adversely affect the sperm motility and male fertility. Thus, some of these drugs may also have the potential to be used as contact spermicidal and future contraceptives.
Human sperm membrane contains several ion channels that play an important role in the regulation of sperm intra-and intercellular signaling mechanisms [8] [9] [10] . There is a movement of various ions via these ion channels which allows transfer of information between a sperm and its surrounding environments and mediums [11] .
This communication is vital to correctly guide the sperm through the female reproductive tract and is also necessary for acquiring fertilization ability and interacting with the ovum for fertilization [12] .
Over time, various ion channels have been discovered in the sperm cell membrane. Among these, Ca 2+ , K + , Na + and anion channels like Cl -are important and are widely distributed on the head and flagellum and account for a vital role in regulating sperm function, which includes motility, viability, capacitation and acrosome reaction (AR) [13] . The difference in ion concentration between the surrounding environment and the cytoplasm of the sperm is essential for normal motility [14] . Ion concentration gradients across cells not only regulates membrane potential (E m ) through selective ion channels, but also the permeable ions can modulate various enzymes that further influences channel activity which leads to additional E m changes and ion flow. So the rates and direction of ion-flow through different channels and ion-exchangers is ultimately governed by E m . Drugs that selectively inhibit ion channel function can inhibit sperm function and motility and prevent fertilization [18] .
VGSCs blockers are an important class of drugs that have a membrane stabilizing activity. They block ligands and voltages-gated channels and impair conduction of Na + through sodium channels.
The resulting prolonged inhibition of the influx of Na + through the channel produces depolarization of the resting potential of the cell. Overall, there is partial or total inhibition of action potential from being propagated across the cell membrane, thus stabilizing the E m [19] . Drugs which block VGSCs belong to three distinct pharmacological classes including class-栺 antiarrhythmic agents, some anticonvulsants and local anesthetics [20] .
Class-栺 antiarrhythmic drugs are potent Na + channel blockers that are further classified into three categories based upon their antiarrhythmic action. Class-栺 includes the drugs quinidine, procainamide and disopyramide [21] . Class-栺 agents are grouped by their effect on the Na + channel and cardiac action potentials, which are called Membrane Stabilizing Agents [22] .
The anticonvulsants are a diverse group of pharmacological agents used in the treatment of epileptic seizures. Among the antiepileptics, the drugs with Na + channel blocking activity as their primary mechanism of action includes phenytoin, carbamazepine, and oxcarbazepine and lamotrigine. These drugs block VGSCs and prolong their inactivated state, which inhibits the rapid and repetitive generation of action potentials across the cell membrane [23] .
Drugs with membrane stabilizing potential are potent inhibitors of sperm motility [24] , like indormin and propranolol inversely affect in vitro human sperm motility and viability [8, 25] . This anti-motility effect made these drugs to be evaluated as vaginal spermicidals. In a clinical trial, propranolol showed favorable results as a vaginal spermicidal. Similarly, several antiarrhythmic drugs have shown a sperm immobilizing effect due to their membrane stabilizing activity by blocking voltage dependent sodium channels [26] .
It is possible that VGSCs blockers affect sperm motility and male fertility. Therefore, the present study was designed to investigate the effects of Na + channel blocking drugs belonging to antiarrhythmic and antiepileptics classes, on the in-vitro motility of human sperm.
These drugs were evaluated for their toxic effects on sperm motility parameters and their potential used as contact spermicidal.
Materials and methods

Drugs and chemicals
Commercially 
Drug samples preparation
Stock solutions for the drugs were prepared in phosphate-buffered saline (Dulbecco 'A', pH 7.3). For preparing the stock solutions of drugs insoluble in phosphate-buffered saline, the drug was dissolved in 5% ethanol or 1% dimethyl sulfoxide and final volume was adjusted with phosphate-buffered saline (both solvents not affecting sperm parameters at the given strength). Stock solutions were then further diluted with phosphate-buffered saline to make various concentrations of drug samples.
Motility analysis
Computer Assisted Semen Analyzer (CASA) was used to examine the in vitro effect of various VGSCs blockers on sperm motility Total motility is the sum of % rapid progressive motility and % slow progressive motility and all parameters were determined in accordance with WHO criteria [27] .
Reversibility study
Motility of treated sperm samples and the sperm samples without a drug (negative control) were first analyzed with the help of CASA. Then these samples were centrifuged at 2 500 r/min for 5 min. The sperm pellets so obtained were washed with phosphatebuffered saline three times and re-suspended in phosphate-buffered saline without any drug. The washed samples were re-suspended in phosphate-buffered saline and incubated for 30 min at 37 曟 in the incubator and motility parameters were again measured. Motility parameters were compared in the treated and recovery samples. samples and the control sample using GraphPad Prism 6. The data were considered statistically significant at P<0.05.
Results
Dose response analysis of VGSCs blockers on human sperm motility
Effects of amiodarone, procainamide and disopyramide on the invitro motility of human sperms were estimated by CASA. All these drugs showed the dose dependent inhibition of total motility with significant reduction (P<0.05) at the maximum concentration of 200 µM when compared with the control.
Significant reduction of the total sperm motility treated by amiodarone was observed at concentrations 1.6 µM and above compared to control (P<0.05). The 8 µM concentration of the drug reduced the total motility to 40% that was lower than the normal value according to WHO standards (total motility >50%) ( Table 1) .
On the other hand, procainamide resulted in significant (P<0.05) reduction in sperm motility at concentrations of 8 µM (total motility 20% ) and above when compared with control (Table 2) .
At the lower concentrations of 0.32 µM and 1.6 µM, the reduction in total motility by procainamide was not significant (P>0.05 compared to control) with values of 75% and 70% respectively. The IC 50 values for amiodarone and procainamide calculated by nonlinear regression analysis were found to be 2.53 µM and 5.32 µM respectively ( Figure 1 ). Of all the three VGSCs blocker drugs, disopyramide was the most potent inhibitor of in vitro human sperm motility (Table 3 ).
Significant reduction in the total sperm motility was observed even at the lowest concentration of 0.32 µM when compared with control (P<0.05). The total sperm motility at a concentration of 0.32 µM was 35% while it was reduced to 0% at concentration of 40 µM concentration of disopyramide. On the contrary, at the maximum concentration of 200 µM, procainamide reduced the total motility to 0% while amiodarone reduced it to 10% (Table 1 , 2). The IC 50 value for disopyramide was 0.37 µM that was lowest of all three drugs (Figure 1 ). (Table 4) .
There was significant recovery of sperm motility in all samples with maximum reversibility observed in samples treated with disopyramide. Although not completely recovered, total motility increased significantly (P<0.05) in recovery samples when compared to the treated samples, after the removal of each drug. This showed that while disopyramide possessed strong but reversible inhibitory effects on human sperm motility; procainamide exerted a longer lasting and irreversible inhibitory effect (Table 4 ).
Effect of amiodarone, procainamide, disopyramide on the viability of human sperm in vitro
The viability of human spermatozoa treated with a 200 µM concentration of blockers of amiodarone, procainamide, disopyramide, was checked using the trypan blue exclusion test. All these drugs demonstrated potent spermicidal effects. There was significant reduction in the viability of human spermatozoa when compared with control (P<0.05). The percentage of viable spermatozoa in control samples and others treated with a 200 µM concentration of amiodarone, procainamide and disopyramide were 87%, 41%, 33% and 30%, respectively. There was no significant difference in inhibition of sperm viability among the three drugs (Table 5 ). 
Dose response analysis of carbamazepine, oxcarbazepine, phenytoin, and lamotrigine on the human sperm motility
Effects of four Anti-Epileptic drugs that block VGSCs including carbamazepine, oxcarbazepine, phenytoin, and lamotrigine, on the in vitro motility of human sperm was estimated by CASA.
Carbamazepine, phenytoin and lamotrigine showed significant Table 4 Reversibility of effects of Amiodarone, Procainamide and Disopyramide on total sperm motility (Mean ± SD, n = 4). Table 3 Effect of various concentrations of disopyramide on motility parameters. Total motility = rapid progressive% + slow progressive % (WHO standard).
Mean ± SD, n = 4. dose dependent inhibition of total motility compared to control (P<0.05), and no significant effects observed by oxcarbazepine at any concentration (Table 6, 7, 8, 9) .
Phenytoin demonstrated potent and significant inhibition of total sperm motility when compared with control (P<0.05). The total motility at the concentrations of 40 and 200 µM was 4% and 0%, respectively (Table 8) . Alternatively, lamotrigine reduced total motility to 18% at 200 µM concentration ( Table 9 ).
All drugs at lower concentrations observed similar inhibitory effects on total sperm motility. Carbamazepine initially caused a slight increase in total motility at 0.32 µM with insignificant inhibitions at 1.60 and 8.00 µM concentrations where the total motility was 63%
and 64% (P>0.05) (Table 6 ). However, significant inhibition of total sperm motility was observed at 40 and 200 µM concentrations of carbamazepine when compared with control having values 26% and 14%, respectively (P<0.05) ( Table 6 ).
Phenytoin possessed lowest IC 50 value for the reduction in total sperm motility compared to lamotrigine and carbamazepine. The concentrations of drugs that reduced total sperm motility to 50% of control were 2.76, 14.16 and 20.29 µM for phenytoin, lamotrigine Table 6 Effect of various concentrations of carbamazepine on motility parameters. Total motility = rapid progressive%+slow progressive % (WHO standard).
Mean ± SD, n = 4. Table 7 Effect of various concentrations of oxcarbazepine on motility parameters. Total motility = rapid progressive%+slow progressive % (WHO standard).
Mean ± SD, n = 4. Table 8 Effect of various concentrations of phenytoin on motility parameters. Total motility = rapid progressive%+slow progressive % (WHO standard).
Mean ± SD, n = 4. Table 9 Effect of various concentrations of lamotrigine on motility parameters. Total motility = rapid progressive%+slow progressive % (WHO standard).
Mean ± SD, n = 4. and carbamazepine, respectively (Figure 2 ). Oxcarbazepine did not show any notable effect upon the individual motility parameters (Table 7) . Carbamazepine initially caused a slight rise in rapid progressive motility followed by a concentration dependent inhibition. These results indicated that phenytoin possessed more potent and deleterious effects on human sperm motility as compared to carbamazepine and lamotrigine.
3.5. Reversibility of the effects of carbamazepine, oxcarbazepine, phenytoin, and lamotrigine on in vitro human sperm motility CASA analysis was done on the aliquots of spermatozoa treated with a 200 µM concentration of drugs to estimate the reversibility of the effects of each drug. It was observed that inhibitory effects of all drugs on human sperm motility were reversed upon the removal of the drug from the sperm samples (Table 10 ).There was significant recovery of sperm motility in all samples with maximum reversibility observed in samples treated with phenytoin. These results indicated that inhibitory effects of carbamazepine, phenytoin, and lamotrigine on in vitro sperm motility were reversible, and the total motility increased upon the removal of these drugs.
3.6. Effects of carbamazepine, oxcarbazepine, phenytoin, and lamotrigine on the viability of human sperm and lamotrigine were 84%, 45%, 23% and 37%, respectively.
Phenytoin was the most potent spermicidal among all drugs (Table   11 ). Table 11 Viability of sperm in the presence of carbamazepine, phenytoin and lamotrigine (Mean ± SD, n = 4). 
Discussion
Among the factors that affect male fertility and normal sperm parameters, drugs and chemical compounds play an important role [28] . Many drugs used for other ailments have the potential to adversely affect sperm motility and viability [29] . Presence of VGSCs on the membrane of human sperm and their important role in sperm function including motility, capacitation and AR is evident [17] .
Therefore, there is a possibility that blockers of sodium channels may affect the sperm motility and viability. In this study, it has been shown that VGSCs blockers considerably impaired in-vitro sperm Table 10 Reversibility of effects of carbamazepine, phenytoin, and lamotrigine on total sperm motility (Mean ± SD, n = 4). VGSCs are complex membrane proteins composed of α and one or more auxiliary 毬 -subunits [32, 33] . The 毩 -subunit is a large protein and contains an ion-conducting aqueous pore and can function without the 毬 -subunit as a Na + channel [34] . Nine different VGSCs subunits have been found in mammals. They are further classified based upon their sensitivity towards a selective blocker tetrodotoxin (TTX).
The TTX-sensitive 毩 -subunits includes Nav 1.1, 1.2, 1.3, 1.4, 1.6, and 1.7. The TTX resistant 毩 -subunits include Nav 1.5, 1.8, and 1.9 [35] . Excluding only Nav 1.1 and 1.3, all other VGSCs have been detected in mature sperm. The VGSCs (i.e., Nav 1.2, 1.4 and 1.7) are mainly found in the area of connecting piece of the sperm, which plays an important role in sperm signaling [13] . Nav 1.8 is located at the flagellum and around the neck region, and regulates flagellum activity and sperm motility [17] .
All the three antiarrhythmic drugs reduced sperm motility in a dosedependent manner. Disopyramide showed more potent inhibition of in vitro human sperm motility than procainamide and amiodarone.
Semen plasma concentrations of the drugs are unknown. However, the reported plasma drug concentrations for disopyramide, amiodarone and procainamide were 2.00-4.00 µg/mL [36, 37] , 0.37 µg/mL [38] and 3.50-4.60 µg/mL [39] , respectively. The drugs might not have achieved this much concentration in the semen, but the semen drug concentrations should be determined to rule out the potential hazardous effects of the drug on sperm motility and fertility. Viability of sperm was also affected significantly
showing the spermicidal activity in all drugs. Amiodarone abolished ejaculated spermatozoa motility at higher concentrations, and it should be further studied as contact spermicidal.
Structurally amiodarone, procainamide and disopyramide are different, but they follow the backbone structure that is common to many antiarrhythmic and local anesthetics [40, 41] . The dissimilarity in the lipophilic and hydrophilic portions among these compounds plays an important role in the pharmacokinetics and pharmacodynamics properties of these drugs [42, 43] . It is possible that the variability in the inhibitory effects of these drugs on sperm motility and viability was due to the differences in their lipophilic or hydrophilic moieties.
Antiepileptic drugs including carbamazepine, phenytoin, and lamotrigine inhibited sperm motility in a dose-dependent manner, except oxcarbazepine, which did not show any significant effect on in-vitro motility of sperm at any concentration. Phenytoin showed the most potent anti-motility effects as compared to carbamazepine and lamotrigine. All the values were below the normal value of total sperm motility (total motility must be >50%, WHO standard).
The reported semen drug concentration of phenytoin is 0.97 µg/mL [38, 43] , which shows that enough high levels could have been achieved with phenytoin therapy in human semen that can adversely affect the motility of sperm. The semen drug concentrations of carbamazepine and lamotrigine are unknown. However, the reported plasma drug concentrations of these drugs are 5-12 µg/mL [44] and 1-4 µg/mL [45] , respectively. Since both carbamazepine and lamotrigine are highly lipid soluble drugs, they may cross the blood testicular barrier like other psychotropic drugs [35] , providing a high possibility to appear in the seminal fluids and interfere with sperm function. Hence, the seminal concentrations of these drugs are needed to be measured, and in vivo effects are also recommended to be assessed.
Phenytoin belongs to a class of compounds known as hydantoins.
Imidazolidinone ring of phenytoin is believed to be involved in VGSCs blocking activity, as substitution on this group modifies the channel blocking activity of its derivatives [46] .
VGSCs blocking drugs in this study influenced all the motility parameters significantly except the percentage of non-progressive motility, which did not changed significantly at lower doses. Since these drugs produce a dose dependent block of the VGSCs and more potent blockade of VGSCs in cells, which undergo rapid Em changes [20, 21] , non-progressive sperm may not expressed rapid Em changes, making them less vulnerable to the channel blocking effect of these drugs at lower doses, thus showing no significant changes in percentage of non-progressive motility.
Oxcarbazepine is a structural derivative of carbamazepine, with a ketone in place of the carbon-carbon double bond on the dibenzazepine ring. This difference helps reduce the impact on the liver of metabolizing the drug, and also prevents the serious forms of adverse reactions occasionally associated with carbamazepine [47, 48] . Moreover, oxcarbazepine is less potent than carbamazepine both in animal models of epilepsy and in epileptic patients; clinical doses of oxcarbazepine may need to be 50% higher than those of carbamazepine to obtain VGSCs blockade and seizure control [49] .
These findings may explain the results of this study where at the maximum concentration of 200 µM, oxcarbazepine did not show any significant effect on total motility of human sperm as compared to carbamazepine which significantly reduced the total motility even at 8 µM concentration.
For sperm motility, an adequate E m is necessary and prolong cell membrane depolarization has been associated with low sperm motility [50] . Veratridine a VGSCs activator is reported to affect sperm motility which further establishes the functional role of Na + -channels in mature sperm [17] . It enhanced total motility which was concentration and time dependent. Veratridine acts by inhibiting Na + -channel inactivation after spontaneous channel opening. These facts demonstrate that VGSCs participate in the regulation of human sperm motility, and primarily it is due to the regulation of sodium ion flux across the membrane, which ultimately affects the E m .
Regulation of [pH] i is essential for the function of sperm [14] .
An important mechanism that controls proton concentration in somatic cells operates utilizing the transmembrane Na + gradient.
Changes in [pH] i have been shown to influence sperm motility [51] , which is regulated by voltage-sensitive Na + /H + exchanger [52] and Na + /K + -ATPase pump in the cell membrane. Since the VGSCs also regulate the flux of sodium ions across the membrane, their role in the internal pH maintenance cannot be ruled out. Also the VGSCs blockers inhibit the transmembrane conductance of sodium ions, which may affect the internal pH and ultimately affect the sperm motility. Mechanism of action of these drugs in terms of the blockade of VGSCs and membrane stabilizing activity is well documented. It is highly likely that there are also other effects, which are contributing to impairment of sperm motility.
In conclusion, VGSCs blockers including antiarrhythmic and antiepileptic drugs significantly inhibit in-vitro human sperm motility. This fact emphasizes that these drugs can adversely affect human sperm function. Thus, it is recommended to perform the invivo studies to rule out the potential toxicological effects of these drugs on human semen quality and function. The potent spermicidal activity and motility inhibition also suggest that these drugs could be formulated as contact spermicidal in the future.
